Although the data from Zipk+/− mice and ZIPK knockdown cells support that partial deletion of ZIPK effectively ameliorated neuronal loss and cognitive impairment, we cannot exclude the potential contribution of DAPK1 inhibition by HS38 in the inhibitor treatment experiments. This evidence concerns the gene DAPK3 and Cognitive impairment.